KRKerry-Anne Rye
Kerry-Anne Rye
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kerry-Anne Rye has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Philip J. Barter
Centre for Vascular Research, UNSW Australia, Sydney, Australia
12 shared publications E. Nobecourt
3 shared publicationsJ.R. Gamble
3 shared publicationsM.A. Vadas
3 shared publicationsPhilip J. Barter
3 shared publications- Philip J. Barter
The Heart Research Institute, Sydney, New South Wales, 2042, Australia
3 shared publications
Latest Publications
- 1 July 2015
- Published by Elsevier in Atherosclerosis
- Vol. 241 (1) , e3
Pancreatic beta-cell specific deletion of ABCA1 and ABCG1 perturbs glucose metabolism and increases adiposity in mice due to suboptimal plasma insulin levels
- 1 July 2015
- Published by Elsevier in Atherosclerosis
- Vol. 241 (1) , e3
Pancreatic beta-cell specific deletion of ABCA1 and ABCG1 perturbs glucose metabolism and increases adiposity in mice due to suboptimal plasma insulin levels
- 31 December 2009
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 18, S243
HDL induces anergy to proinflammatory cytokines in endothelial cells through a mild oxidative stress response
- 31 December 2009
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 18, S243
HDL induces anergy to proinflammatory cytokines in endothelial cells through a mild oxidative stress response
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e1180
Abstract: P1154 IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e1180
Abstract: P1154 IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e309
Abstract: P1202 THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e309
Abstract: P1202 THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED
- 31 December 2007
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 16, S167
The Fate of Reconstituted High Density Lipoproteins in Vivo
- 31 December 2007
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 16, S167
The Fate of Reconstituted High Density Lipoproteins in Vivo
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 322
We-W38:5 Effect of inhibiting cholesteryl ester transfer protein on the kinetics of HDL cholesteryl ester transport in plasma: In vivo studies in rabbits
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 322
We-W38:5 Effect of inhibiting cholesteryl ester transfer protein on the kinetics of HDL cholesteryl ester transport in plasma: In vivo studies in rabbits
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 71
Mo-P1:114 Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 71
Mo-P1:114 Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 153
Tu-W16:4 A single infusion of lipid free APO A1 can rescue vascular inflammation
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 153
Tu-W16:4 A single infusion of lipid free APO A1 can rescue vascular inflammation
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 152
Tu-W16:1 HDL and the inhibition of inflammation in vivo
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 152
Tu-W16:1 HDL and the inhibition of inflammation in vivo
- 31 July 2000
- Published by Elsevier in Atherosclerosis
- Vol. 151 (1) , 190
Inhibition of endothelial cell adhesion molecule expression by reconstituted high-density lipoproteins: Determinants and characteristics
- 31 July 2000
- Published by Elsevier in Atherosclerosis
- Vol. 151 (1) , 190
Inhibition of endothelial cell adhesion molecule expression by reconstituted high-density lipoproteins: Determinants and characteristics